<p><b>Number of alpha-SMA positive cells (activated HSCs) expressing IGF-I (A) and IGF-IR (B) in the different stages of fibrosis.</b> Values are displayed as median and interquartile range (IQR).</p
Insulin-like growth factor-I (IGF-I) in human hepatoma cells (HEP-G2) has, in addition to its effect...
Inflammation may have a pathogenic role in the progression of nonalcoholic fatty liver disease (NAFL...
Diabetic and obese patients have a high prevalence of non-alcoholic fatty liver disease (NAFLD). Thi...
<div><p>Background and aims</p><p>Nonalcoholic fatty liver disease is one of the major complications...
BACKGROUND AND AIMS:Nonalcoholic fatty liver disease is one of the major complications of obesity, o...
Background and aimsNonalcoholic fatty liver disease is one of the major complications of obesity, oc...
Insulin and insulin-like growth factor (IGF-1) are mitogenic for fibroblasts and smooth muscle cells...
Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis ...
Objective To correlate circulating levels of insulin-like growth factor (IGF)-I, IGF-II, and IGF bin...
Hepatocyte differentiation, proliferation, and apoptosis are affected by growth factors produced in ...
AbstractRecent evidence that insulin-like growth factor-1 (IGF-1) influences certain properties of H...
Background/Aim: Hepatic stellate cells (HSCs) express α-smooth muscle actin (αSMA) and acquire a pro...
Objective In this study, we aimed to investigate the relationship between the histological features ...
The insulin family consists of insulin, insulin-like growth factor 1 (IGF-1), insulin-like growth fa...
Insulin-like growth factor-I (IGF-I) in human hepatoma cells (HEP-G2) has in addition to its effect ...
Insulin-like growth factor-I (IGF-I) in human hepatoma cells (HEP-G2) has, in addition to its effect...
Inflammation may have a pathogenic role in the progression of nonalcoholic fatty liver disease (NAFL...
Diabetic and obese patients have a high prevalence of non-alcoholic fatty liver disease (NAFLD). Thi...
<div><p>Background and aims</p><p>Nonalcoholic fatty liver disease is one of the major complications...
BACKGROUND AND AIMS:Nonalcoholic fatty liver disease is one of the major complications of obesity, o...
Background and aimsNonalcoholic fatty liver disease is one of the major complications of obesity, oc...
Insulin and insulin-like growth factor (IGF-1) are mitogenic for fibroblasts and smooth muscle cells...
Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis ...
Objective To correlate circulating levels of insulin-like growth factor (IGF)-I, IGF-II, and IGF bin...
Hepatocyte differentiation, proliferation, and apoptosis are affected by growth factors produced in ...
AbstractRecent evidence that insulin-like growth factor-1 (IGF-1) influences certain properties of H...
Background/Aim: Hepatic stellate cells (HSCs) express α-smooth muscle actin (αSMA) and acquire a pro...
Objective In this study, we aimed to investigate the relationship between the histological features ...
The insulin family consists of insulin, insulin-like growth factor 1 (IGF-1), insulin-like growth fa...
Insulin-like growth factor-I (IGF-I) in human hepatoma cells (HEP-G2) has in addition to its effect ...
Insulin-like growth factor-I (IGF-I) in human hepatoma cells (HEP-G2) has, in addition to its effect...
Inflammation may have a pathogenic role in the progression of nonalcoholic fatty liver disease (NAFL...
Diabetic and obese patients have a high prevalence of non-alcoholic fatty liver disease (NAFLD). Thi...